Japan’s Takeda Pharmaceutical Co is looking at making vaccines a core business after completing asset sales to lower debt following its takeover of Shire Plc, Chief Executive Christophe Weber said.
Japan’s Takeda eyes new focus on vaccines after OTC asset sales: CEO
